Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr-Jun;8(2):112-8.
doi: 10.4103/0975-7406.171727.

Antihyperlipidemic effects of Citrus sinensis, Citrus paradisi, and their combinations

Affiliations

Antihyperlipidemic effects of Citrus sinensis, Citrus paradisi, and their combinations

Neelam Mallick et al. J Pharm Bioallied Sci. 2016 Apr-Jun.

Abstract

Objective: Hyperlipidemia, extensively contributes in the progression of coronary heart diseases and atherosclerosis, but may be managed through alterations in the nutritional pattern. Several studies show that diet rich in polyphenols and antioxidants have antiatherogenic effects. Citrus sinensis and Citrus paradisi are widely known for health benefits and have found to produce antioxidant, anti-inflammatory, and hypolipidemic effects, hence current research was planned to determine the hypolipidemic effects of C. sinensis and C. paradisi in rats receiving diet rich in cholesterol.

Materials and methods: All rats were divided into 11 groups each comprising 10 animals: Normal control group and hyperlipidemic control. C. sinensis treated three groups, C. paradisi treated three groups, C. sinensis and C. paradisi combination treated two groups, and group treated atorvastatin. All rats in the respective groups were treated orally with sterile water, juices, and standard drug for 8 weeks and lipid profile was estimated at the end of dosing.

Results: Cholesterol, triglycerides (TGs), and low-density lipoprotein (LDL) were decreased at all the three doses of C. sinensis and C. paradisi but rise in high-density lipoprotein (HDL) was only significant at 8 ml/kg, and 0.3 ml/kg, respectively. Animals received the combination doses of C. sinensis and C. paradisi also showed a highly significant fall in cholesterol, LDL, and TGs, however HDL level was significantly elevated by SPJ-2 combination.

Conclusion: Results suggest that C. sinensis and C. paradisi possess antihyperlipidemic activity due to phytochemicals and other essential nutrients, hence may serve as cardioprotective by preventing thrombosis.

Keywords: Grapefruit; hyperlipidemia; hypocholesterolemic; orange.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hepatic tissue in hyperlipidemia-induced control rats showing hepatocytes surrounded by lipid content
Figure 2
Figure 2
Hepatic tissue in hyperlipidemia-induced rats treated with 0.1 ml/kg of C. paradisi showing minor lipid contents
Figure 3
Figure 3
Hepatic tissues showing no lipid contents in animals that received 0.3 and 0.5 ml/kg of C. paradisi
Figure 4
Figure 4
Hepatic tissues showing no lipid contents in animals that received combination doses of C. paradisi and C. sinensis

Similar articles

Cited by

References

    1. Kanakavalli K, Thillaivanan S, Parthiban P. Hypolipidemic activity of Nathaichoori Chooranam (NC) (Siddha drug) on high fat diet induced hyperlipidemic rats. Int J Pharm Res Sci. 2014;02:104–9.
    1. Centers for Disease Control and Prevention (CDC). Mortality from coronary heart disease and acute myocardial infarction – United States, 1998. MMWR Morb Mortal Wkly Rep. 2001;50:90–3. - PubMed
    1. Wald NJ, Law MR. Serum cholesterol and ischaemic heart disease. Atherosclerosis. 1995;118(Suppl):S1–5. - PubMed
    1. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation. 1995;92:2419–25. - PubMed
    1. Delsing DJ, Offerman EH, van Duyvenvoorde W, van Der Boom H, de Wit EC, Gijbels MJ, et al. Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation. 2001;103:1778–86. - PubMed